Skip to main navigation Skip to search Skip to main content

A Single-Arm, Open-Label, Multi-Center Study of Complete Molecular Response (CMR) in Adult Patients with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Project: Research

Project Details

StatusFinished
Effective start/end date09/27/1205/23/14

Funding

  • Novartis Pharmaceuticals Corporation: $4,500.00